Akèy › Degeneresans makile › North Carolina
Etid klinik pou Degeneresans makile nan North Carolina
11 etid pou Degeneresans makile ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Piedmont Retina Specialists - Greensboro, Greensboro
- North Carolina Retina Associates, Greenville
- Piedmont Retina Specialists - Winston-Salem, Winston-Salem
Ap rekriteFaz 2/3
Laj 50 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Asheville Eye Associates - Western Carolina Retinal Associates, Asheville
- Duke Eye Center, Durham
- Graystone Eye, Hickory
- ak 1 plis
Ap rekriteFaz 2/3
Laj 60 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06635148A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- NC Retina Associates, Cary
- Graystone Eye, Hickory
- North Carolina Retina Associates, Wake Forest
- ak 1 plis
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 18, 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- North Carolina Retina Associates, Cary
- Duke Eye Center, Durham
- North Carolina Retina Associates, Greenville
- ak 1 plis
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
- Duke Eye Center, Durham
Ap rekriteEtid obsèvasyon
Laj 55 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07144137A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Duke Eye Center, Durham
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07425574AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
- Duke Eye Center, Durham
Ap rekriteVolontè an sante akeyi
Laj 50 a 89 · Tout sèks · Mizajou Aug 10, 2026 · NCT06619405A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Asheville Eye Associates, Retina Division (Site 077), Asheville
- NC Retina, Cary
- Graystone Eye, Hickory
- ak 1 plis
Ap rekriteFaz 2/3
Laj 50 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07496567Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
- Wake Forest, NC, Wake Forest
Ap rekriteFaz 1/2
Laj 50 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07587515Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- North Carolina Retina Associates, Cary
- North Carolina Retina Associates, Wake Forest
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT07064759Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Western Carolina Retinal Associates, Asheville
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Dec 3, 2024 · NCT05438732Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.